Sunesis is a pharmaceutical company looking for a succinct and memorable way to speak to analysts and institutional investors about the momentum behind their oncology franchise. Few companies can boast the depth of cell life-cycle knowledge that the Sunesis team possesses - this scientific horse-power, paired with a talented and commercially focused management team positions Sunesis in the top tier of the new breed of cancer-fighters. In a very condensed Annual we were able to clearly express the unique strengths of the company, the power of the technology, and the opportunity for early investors. The design has a bold, structured, and colorful look and feel that makes the success of this pharma leader seem like a chip shot. Hop on board.